Tilray Brands Inc (TLRY)
1.785
+0.04
(+2.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.785
0.00 (0.00%)
After-Hours: 17:36
Tilray Brands Research and Development Expense (Quarterly): 0.106M for Feb. 29, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.106M |
| November 30, 2023 | 0.056M |
| August 31, 2023 | 0.079M |
| May 31, 2023 | 0.18M |
| February 28, 2023 | 0.171M |
| November 30, 2022 | 0.165M |
| August 31, 2022 | 0.166M |
| May 31, 2022 | 0.054M |
| February 28, 2022 | 0.164M |
| November 30, 2021 | 0.515M |
| August 31, 2021 | 0.785M |
| May 31, 2021 | 0.358M |
| February 28, 2021 | 0.127M |
| November 30, 2020 | 0.225M |
| August 31, 2020 | 0.12M |
| May 31, 2020 | 0.4291M |
| February 29, 2020 | 0.53M |
| November 30, 2019 | 0.5057M |
| Date | Value |
|---|---|
| August 31, 2019 | 0.4564M |
| May 31, 2019 | 0.2176M |
| February 28, 2019 | 0.1696M |
| November 30, 2018 | 0.4609M |
| August 31, 2018 | 0.2017M |
| May 31, 2018 | 0.1608M |
| February 28, 2018 | 0.0861M |
| November 30, 2017 | 0.0622M |
| August 31, 2017 | 0.0713M |
| May 31, 2017 | 0.0362M |
| February 28, 2017 | 0.0728M |
| November 30, 2016 | 0.0662M |
| August 31, 2016 | 0.1905M |
| May 31, 2016 | 0.0063M |
| February 29, 2016 | 0.0584M |
| November 30, 2015 | 0.0409M |
| August 31, 2015 | 0.0653M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.054M
Minimum
May 2022
0.785M
Maximum
Aug 2021
0.2705M
Average
0.1755M
Median
Research and Development Expense (Quarterly) Benchmarks
| Clever Leaves Holdings Inc | 0.233M |
| Flora Growth Corp | 0.025M |
| Acasti Pharma Inc | 1.443M |
| Aurinia Pharmaceuticals Inc | 10.23M |
| Edesa Biotech Inc | 0.7045M |